CHOP, Labcorp Partner on Pediatric Diagnostics Innovation Pipeline

Children's Hospital of Philadelphia (CHOP) and Labcorp have announced the creation of a joint pediatric diagnostics innovation pipeline.

The partnership will combine CHOP's pediatric research and clinical expertise with Labcorp's national diagnostic infrastructure, scientific capabilities and commercialization expertise.

"Our shared aim to improve children's health makes this collaboration so powerful," said Stephen R. Master, M.D., Ph.D., division chief and director of metabolic and advanced diagnostics at CHOP, in a statement. "By pairing CHOP's pediatric leadership with Labcorp's nationwide reach, we seek to deliver important new and specialized tests to children and their families more efficiently and at greater scale."
 
CHOP and Labcorp said they will team up to identify, develop and expand new tests and technologies with a goal of streamlining the path from discovery to national availability. Pediatric-specific diagnostics deliver more accurate, age-appropriate insights for children by accounting for their unique biology, developmental stages and physiological ranges—factors that traditional adult-oriented tests often overlook. The collaboration will make novel diagnostics available nationwide across key clinical areas, such as oncology, metabolic disease and autoimmune conditions.
 
Together, the organizations will provide clinicians and health systems with seek to bring breakthrough diagnostics in cancer, genetics, immune disorders and rare diseases to patients sooner and enabling earlier, more precise diagnoses.

"Labcorp and CHOP share a commitment to advancing pediatric care. By combining CHOP's deep pediatric expertise with Labcorp's scientific capabilities and national reach, we can bring pediatric diagnostic innovations to patients faster and make advanced testing accessible to many more families," said Bryan Vaughn, executive vice president, Diagnostics at Labcorp, in a statement.